Related Experiment Video
Updated: Aug 20, 2025
05:40
Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro
Published on: May 5, 2022
3.9K
Modeling Alzheimer's Disease Using Human Brain Organoids
Karina Karmirian1,2, Mariana Holubiec3, Livia Goto-Silva1
1D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Methods in Molecular Biology (Clifton, N.J.)
|November 18, 2022
Summary
Researchers developed human brain organoids from Alzheimer
Area of Science:
- Neuroscience
- Stem Cell Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) is the leading cause of dementia.
- Understanding AD's biological and biochemical processes requires advanced in vitro models.
- Stem cell technology, particularly brain organoids, offers novel research avenues.
Purpose of the Study:
- To detail the protocol for generating brain organoids from AD patients.
- To analyze Alzheimer's disease-related pathology in these organoids.
- To establish a reliable in vitro model for AD drug screening and mechanistic studies.
Main Methods:
- Generation of three-dimensional brain organoids from induced pluripotent stem cells (iPSCs) of AD patients.
- Culturing and analysis of neural cell interactions and tissue characteristics.
- Characterization of beta-amyloid and tau pathological features within the organoids.
Main Results:
- Successful generation of brain organoids from AD patient-derived iPSCs.
- Recapitulation of key Alzheimer's disease pathological hallmarks, including beta-amyloid and tau.
- Demonstration of organoids as a viable model for studying AD pathology.
Conclusions:
- Human brain organoids derived from AD patients effectively model disease-specific pathology.
- These organoids serve as a promising platform for investigating Alzheimer's disease mechanisms.
- The developed model supports in vitro drug testing for potential Alzheimer's therapeutics.
